Recent Patents on Inflammation & Allergy Drug Discovery

Show Articles
Journal Properties
  • Continued as
    Recent Advances in Inflammation and Allergy Drug Discovery
  • Language
    English
  • Number of Articles
    382
  • Abbreviation
    Recent Pat Inflammation Allergy Drug Discovery
  • ISSN
    1872-213X
  • Main Publisher
    Bentham Science Publishers
  • Publisher
    Bentham Science Publishers Ltd.
  • Indian UGC
  • DOAJ (latest)
Description
Recent Patents on Inflammation & Allergy Drug Discovery is dedicated to providing timely updates on pharmaceutical advancements in treating inflammation and allergies. The journal offers a comprehensive overview of recently patented innovations, with a focus on drug discovery and development, serving as an invaluable resource for researchers and industry professionals alike. The journal provides clear summary of drug discovey targeting to inflammation and allergies Key areas covered in this journal include new therapeutic targets, novel drug candidates, drug delivery systems, and cutting-edge research methodologies. Indexed in databases such as CAS and others, this journal reaches a global audience of medicinal chemists, pharmacologists, and clinicians actively involved in the discovery of anti-inflammatory and anti-allergy drugs. It aims to accelerate drug development by disseminating the latest patented technologies and research findings. Stay up-to-date with the latest breakthroughs in inflammation and allergy drug discovery. To access this critical knowledge, explore our website or contact us for subscription options. Submit your work to contribute to the ongoing innovation in this essential field.